Joined Today: 7

SVNT Savient Pharmaceuticals, Stock Message Board

All Messages

SVNT Message Board Home | Join The SVNT Group |

#40: Savient Announces U.S. Court of Appeals Affirmation of the Dismissal of Securities Class Action Complaint
TheMachine	July 19, 2008 01:47:35 AM
Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) today announced that the United States Court of Appeals for the Third Circuit has entered a Judgment affirming the decision... view message ignore post recommend post

#39: Savient Provides Update On Puricase(R) (pegloticase) Biologics License Application
TheMachine	May 7, 2008 11:29:33 AM
Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) today announced an update on plans for filing its Biologics License Application (BLA) for Puricase® (pegloticase) for... view message ignore post recommend post

#38: Savient Pharmaceuticals to Present at 28th Annual Cowen Healthcare Conference on March 18
TheMachine	April 16, 2008 12:41:53 AM
Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) today announced that Paul Hamelin, Senior Vice President, Commercial Operations of Savient Pharmaceuticals will present a... view message ignore post recommend post

#37: Puricase(R) (pegloticase) Meets Pre-Specified Primary Efficacy Endpoint in Two Replicate Phase 3 Studies
NewsBot	December 13, 2007 10:10:26 AM
Pooled Analysis of Secondary Endpoints Shows Statistical Significance in the Reduction of Gout Tophi and Trends in Improvement of Other Secondary Clinical Measures Savient Pharmaceuticals, Inc.... view message ignore post recommend post

#36: SVNT News Savient Pharmaceuticals Reports Fourth Quarter and Year End 2006 Results
NewsBot	March 13, 2007 02:46:00 PM
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) today reported financial results for the three months and year ended December 31, 2006. The Company... view message ignore post recommend post

#35: SVNT News Savient Pharmaceuticals to Hold Fourth Quarter and Year End Financial Results Conference Call on Wednesday, March 14, 2007
NewsBot	March 7, 2007 06:24:00 AM
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) announced today that the company will release financial results for the fourth quarter and year end... view message ignore post recommend post

#34: SVNT News Savient Announces Completion of Patient Enrollment in Phase 3 Trials of Puricase(R) for Treatment-Failure Gout
NewsBot	March 6, 2007 09:43:00 AM
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) announced today that it has reached its Phase 3 enrollment target of 200 patients total, in the two... view message ignore post recommend post

#33: SVNT News Savient Pharmaceuticals Restructures Commercial Operations Following Launch of Authorized Generic
NewsBot	January 5, 2007 01:51:00 PM
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) today announced that following the launch of the Company’s A-B rated authorized generic of... view message ignore post recommend post

#32: SVNT News Savient Pharmaceuticals Announces Launch of Authorized Generic of Oxandrin(R) with Watson Pharmaceuticals
NewsBot	December 29, 2006 06:25:00 AM
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) (“Savient” or “the Company”) announced today that Watson Pharmaceuticals... view message ignore post recommend post

#31: SVNT News Savient Pharmaceuticals Announces Appellate Court Decision in Patent Infringement Lawsuit against Sandoz Pharmaceuticals and Upsher-Smith Laboratories
NewsBot	December 12, 2006 03:52:00 PM
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) announced today that the United States Court of Appeals for the Federal Circuit in Washington, D.C.... view message ignore post recommend post

#30: SVNT News Savient Pharmaceuticals Announces Modification of Temporary Restraining Order in Patent Infringement Lawsuit against Sandoz Pharmaceuticals and Upsher-Smith Laboratories
NewsBot	December 11, 2006 06:30:00 AM
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) announced today that the U.S. District Court for the District of New Jersey, after considering ... view message ignore post recommend post

#29: SVNT News Savient Pharmaceuticals Obtains Temporary Restraining Order in Patent Infringement Lawsuit Against Sandoz Pharmaceuticals and Upsher-Smith Laboratories
NewsBot	December 5, 2006 06:08:00 AM
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) announced today that it was granted late yesterday a Temporary Restraining Order (“TRO”) ... view message ignore post recommend post

#28: SVNT News Savient Pharmaceuticals Files Patent Infringement Lawsuit Against Sandoz Pharmaceuticals and Upsher-Smith Laboratories
NewsBot	December 4, 2006 06:00:00 AM
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) announced today that it has filed a lawsuit in the U.S. District Court for the District of New ... view message ignore post recommend post

#27: SVNT News Savient Pharmaceuticals to Present at Lazard Capital Markets Third Annual Life Sciences Conference
NewsBot	November 22, 2006 04:00:00 AM
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT), a biopharmaceutical company focused on developing, manufacturing and marketing novel therapeutic ... view message ignore post recommend post

#26: SVNT News Savient Pharmaceuticals to Present at Rodman & Renshaw Eighth Annual Healthcare Conference
NewsBot	November 2, 2006 08:26:00 AM
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT), a biopharmaceutical company focused on developing, manufacturing and marketing novel therapeutic ... view message ignore post recommend post

Group Home | Login if you want to post a message